US-based pharma company Pfizer has withdrawn an application for emergency-use authorization of its COVID-19 vaccine in India. Pfizer withdraws emergency use request for its COVID vaccine in India | Photo Credits: Pixabay
New Delhi: US-based pharma company Pfizer has withdrawn an application for emergency-use authorization of its COVID-19 vaccine in India, the company spokesperson said.
The company participated in a subject expert committee meeting of the Drug Regulatory Authority of India (DGCI) on Wednesday, following which it has decided to withdraw its application at this time.
In a statement, the Pfizer Company spokesperson said it will continue to engage with the DGCI and resubmit its approval request with additional information as it becomes available in the near future.